Harbour Investments, Inc. Fate Therapeutics Inc Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$47.84 - $64.34 $47 - $64	-1 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $2,963 - $4,786	-50 Reduced 98.04%	1 $0
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $3,362 - $4,626	50 Added 5000.0%	51 $4,000
Q1 2021 Aug 17, 2021	BUY	$72.16 - $117.4 $72 - $117	1 New	1 $0

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $235M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.